Ina Frank

Ina Frank is a Regulatory Affairs professional specializing in biosimilars. They currently serve as the Head of Regulatory Affairs Biopharma at Sandoz, a position they have held since 2022. Previously, Ina was the Head of Regulatory Affairs Biosimilars at Fresenius Kabi from 2018 to 2022, and they held various regulatory positions at notable companies such as Boehringer Ingelheim, Abbott, and Biotest AG. Ina's extensive experience includes leadership roles in global regulatory activities and the management of safety and risk minimization for monoclonal antibodies.